Back to Library

Johnson & Johnson

Brad’s Journey from Crohn’s Disease Diagnosis to Determination

Written by
Johnson & Johnson logoJohnson & Johnson
• Published September 26, 2026 • Updated September 26, 2026 Sponsored Content
Brad’s Journey from Crohn’s Disease Diagnosis to Determination

For Brad, being a firefighter isn’t just a job, it’s who he is. For more than a decade, he has answered calls, responded to emergencies, and helped others when they needed him most.

Then, one night at the fire station, Brad faced a different kind of emergency—one that started with a burning sensation in his gut.

Johnson & Johnson creative content

"... we got up to run a call. I felt a weird, burning sensation in my gut getting worse and worse." 
—Brad, living with Crohn's disease

Brad would soon find an answer to his unexplained abdominal pain: a diagnosis of Crohn’s disease.

Symptoms Heating Up

After that night, Brad’s symptoms escalated. Along with the pain, he was making frequent trips to the bathroom—sometimes every few minutes.

Johnson & Johnson creative content

“I got to the point where the pain was too bad, and I wasn’t able to go to work...using the restroom every 5 to 10 minutes really took a toll on me.” 
—Brad, living with Crohn’s disease

Eventually, the symptoms became so severe that he had to step away from the work he loved.

A visit to his doctor led to a referral to a gastroenterologist and a colonoscopy, which confirmed the diagnosis of Crohn’s disease.

Crohn’s Disease

Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract.

Symptoms can include:

  • Persistent diarrhea
  • Abdominal cramps and pain
  • Fatigue
  • Weight loss
  • Urgent need to move bowels
  • Sensation of incomplete bowel movements

These symptoms may come and go over time. While there is no known cure, there are treatment options available that may help reduce symptoms and achieve remission.

Brad’s doctor prescribed a medication to treat his symptoms, but he quickly realized that it wasn’t working for him.

Determined to find relief, Brad connected with a new gastroenterologist who introduced another option: a clinical trial for TREMFYA® (guselkumab). TREMFYA is a prescription medicine used to treat adults with moderately to severely active Crohn’s disease or moderately to severely active ulcerative colitis.

Johnson & Johnson creative content

Answering the Call with TREMFYA

After beginning TREMFYA, Brad started seeing results in about 4 to 5 weeks.

With proper training by a healthcare professional, Brad is able to self-administer his TREMFYA treatment. He has experienced symptom relief that has allowed him to return to the firehouse.

And today, since Brad is in remission, he’s back in the field—responding to calls, supporting his team, and spending time with his family.

“TREMFYA allowed me to get back and work in the field that I love.” 
—Brad, living with Crohn’s disease

To Brad, remission means feeling like himself again.

“TREMFYA has brought me back to being the person that I am and to living symptom-free.” 
—Brad, living with Crohn’s disease

Today, Brad is symptom free.

In a clinical trial of patients receiving TREMFYA, ~5 out of 10 patients achieved clinical remission at 12 weeks, and ~6 out of 10 patients achieved clinical remission at 1 year. Reductions in bowel movements and abdominal pain were observed as early as 4 weeks. Individual results may vary.

Johnson & Johnson creative content

“The nice thing about it is I don’t have to go to an IV infusion center... I just take it right there in my kitchen.” 
—Brad, living with Crohn’s disease

TREMFYA is administered as injections under the skin of 400 mg or infusions through a vein of 200 mg at weeks 0, 4, and 8, followed by injections under the skin of 100 mg every 8 weeks or 200 mg every 4 weeks.

If your healthcare provider decides that you or a caregiver may be able to give your injections of TREMFYA at home, you should receive training on the right way to prepare and inject TREMFYA. Do not try to inject yourself until you have been trained by your healthcare provider.

Patient experience may vary. The patient in this promotional article is sharing his individual experiences and has been compensated for his time. This promotional resource is brought to you by Johnson & Johnson.

Talk to your doctor about TREMFYA and explore what’s possible.

Visit TREMFYA.com to learn more about TREMFYA for Crohn’s disease.


IMPORTANT SAFETY INFORMATION
What is the most important information I should know about TREMFYA®? 
TREMFYA® is a prescription medicine that may cause serious side effects, including:

  • Serious Allergic Reactions. Stop using TREMFYA® and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction: 
    • fainting, dizziness, feeling lightheaded (low blood pressure) 
    • swelling of your face, eyelids, lips, mouth, tongue or throat 
    • trouble breathing or throat tightness 
    • chest tightness 
    • skin rash, hives
    • itching
  • Infections. TREMFYA® may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA® and may treat you for TB before you begin treatment with TREMFYA® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA®. 
    Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including: 
    • fever, sweats, or chills 
    • muscle aches 
    • weight loss 
    • cough 
    • warm, red, or painful skin or sores on your body different from your psoriasis 
    • diarrhea or stomach pain 
    • shortness of breath 
    • blood in your phlegm (mucus) 
    • burning when you urinate or urinating more often than normal
  • Liver Problems. With the treatment of Crohn's disease or ulcerative colitis, your healthcare provider will do blood tests to check your liver before and during treatment with TREMFYA®. Your healthcare provider may stop treatment with TREMFYA® if you develop liver problems. Tell your healthcare provider right away if you notice any of the following symptoms: 
    • unexplained rash 
    • vomiting 
    • tiredness (fatigue) 
    • yellowing of the skin or the whites of your eyes 
    • nausea 
    • stomach pain (abdominal) 
    • loss of appetite 
    • dark urine

Do not use TREMFYA® if you have had a serious allergic reaction to guselkumab or any of the ingredients in TREMFYA®.
Before using TREMFYA®, tell your healthcare provider about all of your medical conditions, including if you:

  • have any of the conditions or symptoms listed in the section "What is the most important information I should know about TREMFYA®?" 
  • have an infection that does not go away or that keeps coming back.
  • have TB or have been in close contact with someone with TB.
  • have recently received or are scheduled to receive an immunization (vaccine). You should avoid receiving live vaccines during treatment with TREMFYA®.
  • are pregnant or plan to become pregnant. It is not known if TREMFYA® can harm your unborn baby.
    Pregnancy Registry:  If you become pregnant during treatment with TREMFYA®, talk to your healthcare provider about registering in the pregnancy exposure registry for TREMFYA®. You can enroll by visiting [www.mothertobaby.org/ongoing-study/tremfya-guselkumab](https://www.mothertobaby.org/ongoing-study/tremfya-guselkumab), by calling 1-877-311-8972, or emailing MotherToBaby@health.ucsd.edu. The purpose of this registry is to collect information about the safety of TREMFYA® during pregnancy.
  • are breastfeeding or plan to breastfeed. It is not known if TREMFYA® passes into your breast milk.

Tell your healthcare provider about all the medicines you take,  including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of TREMFYA®? 
TREMFYA® may cause serious side effects. See "What is the most important information I should know about TREMFYA®?" 
The most common side effects of TREMFYA® include: respiratory tract infections, headache, injection site reactions, joint pain (arthralgia), diarrhea, stomach flu (gastroenteritis), fungal skin infections, herpes simplex infections, stomach pain, bronchitis, feeling very tired (fatigue), fever (pyrexia), and skin rash.
These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects.
Use TREMFYA® exactly as your healthcare provider tells you to use it.
Please read the full Prescribing Information, including Medication Guide, for TREMFYA® and discuss any questions that you have with your doctor. 
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. 
Dosage Forms and Strengths: TREMFYA® is available as 100 mg/mL and 200 mg/mL for subcutaneous injection and as a 200 mg/20 mL (10 mg/mL) single dose vial for intravenous infusion.
WHAT IS TREMFYA® (guselkumab)?
TREMFYA® is a prescription medicine used to treat adults with moderately to severely active ulcerative colitis.
TREMFYA® is a prescription medicine used to treat adults with moderately to severely active Crohn's disease.
cp-510994v2
Please see full Prescribing Information and Medication Guide for TREMFYA.
© Johnson & Johnson and its affiliates 2026 10/26 cp-597575v1

Johnson & Johnson creative content